4.7 Article

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression

期刊

DEVELOPMENT
卷 136, 期 8, 页码 1339-1349

出版社

COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.033951

关键词

Nanog; hESCs; Activin; Nodal; Smad2/3; Neuroectoderm; Endoderm; Mesendoderm; Extraembryonic; Mouse; Human

资金

  1. Medical Research Council [G0300723, G0701448, G0800784, G0800784B] Funding Source: researchfish
  2. MRC [G0300723, G0800784, G0701448] Funding Source: UKRI
  3. Medical Research Council [G0300723, G0800784, G0701448] Funding Source: Medline

向作者/读者索取更多资源

The pluripotent status of embryonic stem cells (ESCs) confers upon them the capacity to differentiate into the three primary germ layers, ectoderm, mesoderm and endoderm, from which all the cells of the adult body are derived. An understanding of the mechanisms controlling pluripotency is thus essential for driving the differentiation of human pluripotent cells into cell types useful for clinical applications. The Activin/Nodal signalling pathway is necessary to maintain pluripotency in human ESCs and in mouse epiblast stem cells (EpiSCs), but the molecular mechanisms by which it achieves this effect remain obscure. Here, we demonstrate that Activin/Nodal signalling controls expression of the key pluripotency factor Nanog in human ESCs and in mouse EpiSCs. Nanog in turn prevents neuroectoderm differentiation induced by FGF signalling and limits the transcriptional activity of the Smad2/3 cascade, blocking progression along the endoderm lineage. This negative-feedback loop imposes stasis in neuroectoderm and mesendoderm differentiation, thereby maintaining the pluripotent status of human ESCs and mouse EpiSCs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据